Use of immunochemical fecal occult blood tests to extend surveillance colonoscopy in people with elevated colorectal cancer risk: A retrospective cohort study

被引:0
|
作者
Wassie, M. [1 ]
Cock, C. [1 ]
Bampton, P. [1 ]
Winter, J. [1 ]
Young, G. [1 ]
Simpson, K. [3 ]
Saluja, H. [2 ]
Chuang, A. [2 ]
Fraser, R. [3 ]
Symonds, E. [1 ,4 ]
机构
[1] Flinders Univ S Australia, Flinders Hlth & Med Res, Canc Res, Adelaide, SA, Australia
[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Med, Adelaide, SA, Australia
[3] Flinders Med Ctr, Dept Gastroenterol & Hepatol, Adelaide, SA, Australia
[4] Flinders Med Ctr, Bowel Hlth Serv, Adelaide, SA, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
88
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [41] Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study
    Gimeno-Garcia, Antonio Z.
    Quintero, Enrique
    Nicolas-Perez, David
    Hernandez-Guerra, Manuel
    Parra-Blanco, Adolfo
    Jimenez-Sosa, Alejandro
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (09) : 1062 - 1067
  • [42] Comparison of fecal occult blood tests for screening of colorectal neoplasia: A prospective study with total colonoscopy.
    Han, DS
    Park, JY
    Lee, OY
    Sohn, JH
    Yoon, BC
    Choi, HS
    Hahm, JS
    Lee, MH
    Khee, CS
    Park, KN
    Park, IK
    GASTROENTEROLOGY, 1997, 112 (04) : A574 - A574
  • [43] The impact of antithrombotics on immunochemical fecal occult blood testing for colorectal cancer screening
    Van der Voort, V.
    Wauters, L.
    Dobbels, P.
    Hendrickx, K.
    Casneuf, V.
    Vandervoort, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: A prospective cohort study in Japan
    Lee, Kyung-Jae
    Inoue, Manami
    Otani, Tetsuya
    Iwasaki, Motoki
    Sasazuki, Shizuka
    Tsugane, Shoichiro
    CANCER DETECTION AND PREVENTION, 2007, 31 (01): : 3 - 11
  • [45] Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer
    Hogberg, Cecilia
    Karling, Pontus
    Rutegard, Jorgen
    Lilja, Mikael
    Ljung, Thomas
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2013, 31 (04) : 209 - 214
  • [46] ASSOCIATION OF COLORECTAL CANCER RISK WITH CUMULATIVE FECAL IMMUNOCHEMICAL TESTS VERSUS COLONOSCOPY IN A POPULATION-BASED CASE CONTROL STUDY
    Kim, Hyun-Soo
    Park, Geunu
    Park, So Hee
    Cha, Jae Myung
    Kim, Joo Sung
    Kim, Won Ho
    GASTROENTEROLOGY, 2018, 154 (06) : S770 - S771
  • [47] USE OF FECAL IMMUNOCHEMICAL TESTING AND BLOOD-BASED BIOMARKERS FOR COLORECTAL CANCER RISK PREDICTION IN SYMPTOMATIC PATIENTS REFERRED FOR COLONOSCOPY
    Mansvelders, Mees S.
    Kleif, Jakob
    Kahn, Caroline L.
    Andersen, Malene R.
    Feng, Fan
    Jackson, Laurel
    Rasmussen, Morten
    Jorgensen, Lars N.
    Vilandt, Jesper
    Seidelin, Jakob B.
    Heijboer, Annemieke
    Gawel, Susan H.
    Davis, Gerard J.
    Therkildsen, Christina
    GASTROENTEROLOGY, 2024, 166 (05) : S979 - S979
  • [48] Characteristics of colorectal adenomas identified by colonoscopy, their immunochemical fecal occult blood measurements and contribution to test specificity
    Rozen, Paul
    Hazazi, Rachel
    Levi, Zohar
    Waked, Amal
    Vilkin, Alex
    Maoz, Eran
    Birkenfeld, Swomo
    Leshno, Moshe
    Niv, Yaron
    GASTROENTEROLOGY, 2008, 134 (04) : A484 - A484
  • [50] Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy
    Heitman, Steven J.
    Au, Flora
    Manns, Braden J.
    Mcgregor, S. Elizabeth
    Hilsden, Robert J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (08) : 912 - 917